CD BioSciences Reveals Its Capabilities in Conducting Proof of Concept Research

CD BioSciences, a professional US provider of integrated solutions for clinical trials development, has revealed its capabilities of conducting Proof of Concept (PoC) studies and pivotal clinical research for drug development scientists in biological and pharmaceutical institutes and companies.

Alfa Chemistry Announced to Supply Derivatization Reagents for Analytical Testing Scenarios

Earlier this month, Alfa Chemistry announces in a recent statement that the company is starting to provide derivatization reagents of all kinds for customers across the globe. With all the previously released products added together, now the company offers analytical reagents, analytical standards, chromatography standards, and derivatization reagents. In the near future, Alfa Chemistry will continue to add more reagents to meet the increasing demand arising from analytical testing scenarios.

MedAI Launches Artificial Intelligence Drug Discovery (AIDD) Platform to Accelerate Drug Development

To accelerate drug development, MedAI, an expert of AI-assisted R&D research company, announces that it has completed the construction of its Artificial Intelligence Drug Discovery (AIDD) Platform. With this platform, scientists at MedAI are now capable of providing innovative solutions for pharmaceutical companies to push forward their drug discovery projects.

Parent Project Muscular Dystrophy’s Duchenne Registry Participant Response Rate Increases Exponentially in 2020 Utilizing THREAD

Year one of The Duchenne Registry powered by THREAD’s decentralized platform sees uptick in survey completion, data collection, and community engagement.

Certa Sine pump makes transporting high-viscosity 3D printing materials easy

Innovative German dental materials manufacturer relies on Certa pump technology to transport high-viscosity 3D printing materials.

Solentim sets new standards in productivity with the launch of ICON™ and STUDIUS™; accelerating assurance rich workflows in the development of new biologics

Solentim launches two new solutions to enhance the development of therapeutic antibodies. ICON™ is a benchtop system for the rapid stratification of high productivity clones and STUDIUS™ is a proprietary software platform that delivers unparalleled data on each cell’s journey through cell line development.

Thermo Fisher Scientific Releases SARS-CoV-2 Optimized Precipitation Reagent* and Enrichment Kits* for Isolating Virus Particles

Vaccine Pods Launches from Stealth to Help Eradicate COVID and Announces Collaboration with Stirling Ultracold for its Vaccine Freezers

Vaccine Pods’ industry-first technology, powered by HCI Energy, boosts capacity and power for ultra-low temperature cold chain storage, enabling organizations to safely store and deliver COVID vaccines

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

Domainex Ltd. has invested in the WAVEdelta instrument from Creoptix AG. This instrument utilizes Grating-Coupled Interferometry to measure target binding and achieves superior resolution to traditional Surface Plasmon Resonance.

EXTENSIVE LINE OF LIQUID STABLE & READY-TO-USE CLINICAL REFERENCE MATERIALS AVAILABLE FROM VERICHEM LABORATORIES

VERICHEM LABORATORIES has announced the availability of an extensive line of ready-to-use, liquid stable Clinical Reference Materials intended intended for the calibration and calibration verification of clinical testing systems.

Abzena announces opening of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

Kyruus Enables Online Scheduling for COVID-19 Vaccine Visits and Facilitates More Than 100,000 Appointments in the First Month

MedAI: Explore Therapeutic Antibody Discovery and Development for Disease Treatment

Organocatalysts Available at Alfa Chemistry Catalysts: High Quality and Cost-Effective

Data Analysis at MedAI: PrediXcan Based Analysis and BSLMM Prediction

Gut Microbiota Bioinformatics Services Now Available by the GutFlora Omics Platform

Gut microbiota bioinformatics services help understand how the gut microbiota colonizes, varies and interacts with the host, and even how to associate with diseases can be of great value in the treatment of these diseases, such as inflammatory bowel disease (IBD), diabetes, mental disorders, and cancers.

European Medicines Agency Selects Panalgo for Real-World Data Analytics

Panalgo's IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.

Pronalyse Division Announced Vaccines Analysis Service to Ensure Vaccine Safety

Pronalyse is dedicated to providing professional analysis services in biopharmaceutical development. Recently, the product manager has announced the vaccines analysis service to ensure the safety, efficacy, purity and potency of vaccine products.

BioPure and Teknomek collaborate to deliver optimum workplace efficiency and hygiene confidence Status message

Teknomek worked in collaboration with BioPure, taking account of employee welfare and clean room risk management, to create the ideal specification to support operational process and minimise risk.

Shimmer’s Verisense® Wearable Sensing Platform Selected for Boston University Brain Health Studies

These studies, which are funded by the American Heart Association, will use wearable sensors to increase knowledge of the links between brain and heart health.